Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Metal Free Lewis Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109336811B introduces a bulky borane-catalyzed route for quinoline-4-carboxylates, eliminating heavy metals and ensuring high-purity pharmaceutical intermediates.
Patent CN107382741B details a high-yield B(C6F5)3 catalyzed hydroamination. Offers cost-effective, scalable routes for pharmaceutical intermediates with minimal impurities.